Get all premium features to the best stock analysis tool

Finranks

Finranks

Company

  • About us

Contact us

  • [email protected]

Follow us

  • Instagram
  • Telegram
  • LinkedIn

All rights reserved.

Privacy PolicyTerms of Conditions
  • Home
  • Markets
  • Screener
  • News
  • About
  1. Home
  2. RVTY
R

Revvity, Inc. (RVTY)

NYQ – Real Time Price. Currency in USD

83.90

-3.22 (-3.70%)

At close: Mar 27, 2026, 4:00 PM EDT

83.90

0.00 (0.00%)

After-hours: Mar 27, 2026, 6:23 PM EDT

  • Summary
  • News
  • Chart
  • Financial
  • Dividends
  • Forecast
  • Ownership
  • Profile

Revvity, Inc.

CountryUnited States
IndustryDiagnostics & Research
SectorHealthcare
IPO DateN/A
CEOPrahlad Singh

About the company

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. The company also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, chemagic, Chitas, CNGnome, DELFIA, DELFIA Xpress, EONIS, EUROArray , EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, GSP, Haoyuan, IDS Immunodiagnosticsystems, IDS-i10, IDS-i10T, IDS-i20, IDS-iSYS, iLab, iQ, LifeCycle, LimsLink, Migele, NeoBase, NeoLSD, NEXTFLEX, Panthera Puncher, PreNAT II, Prime, RONIA, SimplicityChrom, Specimen Gate, Superflex, Symbio, T-SPOT, Vanadis, ViaCord, VICTOR2, and WholePanel brand names, as well as under the Accell, AlphaLISA, AlphaPlex, AlphaScreen, Alpha SureFire, AssayMate, BIOCHIPs, BioLegend, Bioo Scientific, BioQule, Brilliant Violet, Ce3D, CellCarrier, Cellaca, Celigo, Cellometer, cell::explorer, Cell-Vive, Chalice, ChemDraw, CHOSOURCE, Dharmacon, and DharmaFECT brand names. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Key Executives

NamePosition
Dr. Prahlad R. Singh Ph.D.CEO, President & Director
Mr. Bryan A. KippSenior VP of Technology & Licensing
Mr. Joel S. GoldbergSenior VP of Administration, General Counsel & Secretary
Mr. Maxwell KrakowiakSenior VP & CFO
Mr. Stephen Barr WilloughbySenior VP of Investor Relations & Head of ESG
Mr. Tajinder S. VohraSenior Vice President of Global Operations
Ms. Anita GonzalesChief Accounting Officer, VP & Controller

Revvity, Inc.

CountryUnited States
IndustryDiagnostics & Research
SectorHealthcare
IPO DateN/A
CEOPrahlad Singh

Contact Details

Address:77 4th Avenue, Waltham, Massachusetts 02451, United States
Phone:781 663 6900
Website:https://www.revvity.com

Stock Details

Latest SEC Filings

DateTypeDocument
2026-03-16DEF 14Ad21831ddef14a.htm
2026-03-06PRE 14Ad21831dpre14a.htm
2026-02-028-Kpki-20260202.htm
2026-01-138-Kpki-20260112.htm
2025-11-0410-Qrevv-20250928.htm
2025-10-278-Kpki-20251027.htm
2025-10-248-Kd52648d8k.htm
2025-08-0510-Qrevv-20250629.htm
2025-07-288-Kpki-20250728.htm
2025-06-2011-Kd43367d11k.htm
Ms. Madhuri Hegde FACMG, Ph.D.
Senior VP & Chief Scientific Officer
Ms. Magali FourSenior VP and Chief People & Culture Officer
Ms. Miriame VictorSenior VP & Chief Commercial Officer
Ticker Symbol:RVTY
Exchange:NYSE
Fiscal Year:January - December
Reporting Currency:USD
CIK Code:31791
CUSIP Number:714046109
ISIN Number:US7140461093
Employer ID:04-2052042
SIC Code:3826